Indication

Seizure due to isoniazid toxicity

Seizure due to isoniazid toxicity is a severe, life-threatening neurological complication resulting from acute supratherapeutic exposure or overdose of the antitubercular agent isoniazid. Read more about Seizure due to isoniazid toxicity

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Seizure due to isoniazid toxicity therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Seizure due to isoniazid toxicity preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Seizure due to isoniazid toxicity.

Seizure due to isoniazid toxicity is a severe, life-threatening neurological complication resulting from acute supratherapeutic exposure or overdose of the antitubercular agent isoniazid.

It predominantly affects the central nervous system, occurring across all patient populations exposed to toxic levels.

Pathophysiologically, isoniazid inhibits pyridoxine phosphokinase and binds pyridoxal 5'-phosphate, depleting active vitamin B6 and arresting glutamic acid decarboxylase activity.

This depletion profoundly diminishes gamma-aminobutyric acid synthesis, leading to widespread loss of central inhibitory neurotransmission.

Clinically, this manifests as intractable, recurrent generalized tonic-clonic convulsions or status epilepticus that typically resist standard anticonvulsant therapy and are frequently accompanied by profound high-anion-gap lactic acidosis and coma.

Personalize your experience

Follow Seizure due to isoniazid toxicity and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it